-
Loading metrics
Open Access
Peer-reviewed
Research Article
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
-
Raphael Gottardo,
Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Robert T. Bailer,
Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Bette T. Korber,
Affiliation Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Álamos, New Mexico, United States of America
⨯ -
S. Gnanakaran,
Affiliation Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Álamos, New Mexico, United States of America
⨯ -
Joshua Phillips,
Affiliation Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Álamos, New Mexico, United States of America
⨯ -
Xiaoying Shen,
Affiliation Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Georgia D. Tomaras,
Affiliation Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Ellen Turk,
Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Gregory Imholte,
Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Larry Eckler,
Affiliation JPT Peptide Technologies GmbH, Berlin, Germany
⨯ -
Holger Wenschuh,
Affiliation JPT Peptide Technologies GmbH, Berlin, Germany
⨯ -
Johannes Zerweck,
Affiliation JPT Peptide Technologies GmbH, Berlin, Germany
⨯ -
Kelli Greene,
Affiliation Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Hongmei Gao,
Affiliation Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Phillip W. Berman,
Affiliation Baskin School of Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America
⨯ -
Donald Francis,
Affiliation Global Solutions for Infectious Diseases, South San Francisco, California, United States of America
⨯ -
Faruk Sinangil,
Affiliation Global Solutions for Infectious Diseases, South San Francisco, California, United States of America
⨯ -
Carter Lee,
Affiliation Global Solutions for Infectious Diseases, South San Francisco, California, United States of America
⨯ -
Sorachai Nitayaphan,
Affiliation Department of Retrovirology, US Army Medical Component, AFRIMS, Bangkok, Thailand
⨯ -
Supachai Rerks-Ngarm,
Affiliation Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand
⨯ -
Jaranit Kaewkungwal,
Affiliation Center of Excellence for Biomedical and Public Health Informatics BIOPHICS, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
⨯ -
Punnee Pitisuttithum,
Affiliation Vaccine Trial Center and Department of Clinical Tropical Medicine, Mahidol University, Bangkok, Thailand
⨯ -
James Tartaglia,
Affiliation Department of Research and Development, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America
⨯ -
Merlin L. Robb,
Affiliation US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Nelson L. Michael,
Affiliation US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Jerome H. Kim,
Affiliation US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Susan Zolla-Pazner,
Affiliations Veterans Affairs New York Harbor Healthcare System, New York, New York, United States of America, New York University School of Medicine, New York, New York, United States of America
⨯ -
Barton F. Haynes,
Affiliation Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
John R. Mascola,
Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Steve Self,
Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Peter Gilbert,
Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ - [ ... ],
-
David C. Montefiori
* E-mail: david.montefiori@duke.edu
Affiliation Duke University Medical Center, Durham, North Carolina, United States of America
⨯ - [ view all ]
- [ view less ]
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
- Raphael Gottardo,
- Robert T. Bailer,
- Bette T. Korber,
- S. Gnanakaran,
- Joshua Phillips,
- Xiaoying Shen,
- Georgia D. Tomaras,
- Ellen Turk,
- Gregory Imholte,
- Larry Eckler
- Published: September 26, 2013
- https://doi.org/10.1371/journal.pone.0075665